CLINICAL_TRIALS trial_result · 2020-04-24

Clinical Trial Update: A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C [Phase 3]

A long-term safety study (Phase 3) of tenapanor for constipation-predominant irritable bowel syndrome has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Ardelyx | Conditions: Constipation Predominant Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2020-04-24